Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nao Muraoka

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Internal Medicine (Tokyo, Japan)|February 26, 2019
A Cavity Communicating with the Right AtriumTakuya Oyakawa, Nao Muraoka, Kei Iida
Annals of Vascular Diseases|January 15, 2019
Effect of Switching from the Initial Direct Oral Anticoagulant to Another One on Exacerbation of Venous Thromboembolism in Patients with Cancer: A Retrospective StudyTakuya Oyakawa, Nao Muraoka, Kei Iida, et al.
European Journal of Internal Medicine|July 1, 2025
Extended anticoagulation therapy on clinical outcomes in patients with gastrointestinal cancer and isolated distal deep vein thrombosis: Insights from the ONCO DVT StudyYugo Yamashita, Takeshi Morimoto, Nao Muraoka, et al.
International Cancer Conference Journal|June 21, 2019
Cancer-associated cerebral infarction during direct oral anticoagulant treatment in cancer patients: a case seriesTakuya Oyakawa, Hiroyuki Fukuda, Nao Muraoka, et al.
Internal Medicine (Tokyo, Japan)|January 12, 2018
A Patient with a Massive Single Cardiac Metastasis of Lung Adenocarcinoma, Diagnosed via a BiopsyTakuya Oyakawa, Nao Muraoka, Kei Iida, et al.
International Journal of Clinical Oncology|February 14, 2019
Use of direct oral anti-coagulants for the treatment of venous thromboembolism in patients with advanced cancer: a prospective observational studyTakuya Oyakawa, Nao Muraoka, Kei Iida, et al.
Japanese Journal of Clinical Oncology|January 5, 2018
Characteristics of cellular composition in malignant pericardial effusion and its association with the clinical course of carcinomatous pericarditisTakuya Oyakawa, Nao Muraoka, Kei Iida, et al.
Asia-Pacific Journal of Oncology Nursing|December 23, 2024
Frequency of ischemic cardiac events in patients receiving long-term multikinase inhibitor: A report of three casesNao Muraoka, Takuya Oyakawa, Ayano Fujita, et al.
Investigational New Drugs|May 3, 2018
Crizotinib-induced simultaneous multiple cardiac toxicitiesTakuya Oyakawa, Nao Muraoka, Kei Iida, et al.
Cardiology|December 9, 2025
Long-term administration of multikinase inhibitors is a potential risk factor for atherosclerosis in patients with thyroid cancerNao Muraoka, Takuya Oyakawa, Ayano Fujita, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Internal Medicine (Tokyo, Japan)|February 26, 2019
A Cavity Communicating with the Right AtriumTakuya Oyakawa, Nao Muraoka, Kei Iida
Annals of Vascular Diseases|January 15, 2019
Effect of Switching from the Initial Direct Oral Anticoagulant to Another One on Exacerbation of Venous Thromboembolism in Patients with Cancer: A Retrospective StudyTakuya Oyakawa, Nao Muraoka, Kei Iida, et al.
European Journal of Internal Medicine|July 1, 2025
Extended anticoagulation therapy on clinical outcomes in patients with gastrointestinal cancer and isolated distal deep vein thrombosis: Insights from the ONCO DVT StudyYugo Yamashita, Takeshi Morimoto, Nao Muraoka, et al.
International Cancer Conference Journal|June 21, 2019
Cancer-associated cerebral infarction during direct oral anticoagulant treatment in cancer patients: a case seriesTakuya Oyakawa, Hiroyuki Fukuda, Nao Muraoka, et al.
Internal Medicine (Tokyo, Japan)|January 12, 2018
A Patient with a Massive Single Cardiac Metastasis of Lung Adenocarcinoma, Diagnosed via a BiopsyTakuya Oyakawa, Nao Muraoka, Kei Iida, et al.
International Journal of Clinical Oncology|February 14, 2019
Use of direct oral anti-coagulants for the treatment of venous thromboembolism in patients with advanced cancer: a prospective observational studyTakuya Oyakawa, Nao Muraoka, Kei Iida, et al.
Japanese Journal of Clinical Oncology|January 5, 2018
Characteristics of cellular composition in malignant pericardial effusion and its association with the clinical course of carcinomatous pericarditisTakuya Oyakawa, Nao Muraoka, Kei Iida, et al.
Asia-Pacific Journal of Oncology Nursing|December 23, 2024
Frequency of ischemic cardiac events in patients receiving long-term multikinase inhibitor: A report of three casesNao Muraoka, Takuya Oyakawa, Ayano Fujita, et al.
Investigational New Drugs|May 3, 2018
Crizotinib-induced simultaneous multiple cardiac toxicitiesTakuya Oyakawa, Nao Muraoka, Kei Iida, et al.
Cardiology|December 9, 2025
Long-term administration of multikinase inhibitors is a potential risk factor for atherosclerosis in patients with thyroid cancerNao Muraoka, Takuya Oyakawa, Ayano Fujita, et al.
Pageof 4